CONRAY

This brand name is authorized in United States. It is also authorized in Canada, South Africa.

Active ingredients

The drug CONRAY contains one active pharmaceutical ingredient (API):

1	Iotalamic acid UNII XUW72GOP7W - IOTHALAMATE MEGLUMINE
	Iotalamic acid is intended for use as a diagnostic radiopaque medium. It is used in excretory urography, cerebral angiography, peripheral arteriography, venography, arthrography, direct cholangiography, endoscopic retrograde cholangiopancreatography, contrast enhancement of computed tomographic brain images, cranial computerized angiotomography, intravenous digital subtraction angiography and arterial digital subtraction angiography.
	Read more about Iotalamic acid

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CONRAY Solution for injection	MPI, US: SPL/Old	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
V08AA04	Iotalamic acid	V Various → V08 Contrast media → V08A X-ray contrast media, iodinated → V08AA Watersoluble, nephrotropic, high osmolar X-ray contrast media
Discover more medicines within V08AA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	00131237
US	FDA, National Drug Code	0019-0953, 0019-3183
ZA	Health Products Regulatory Authority	D/28/212